SCHEMBL5227281

SCHEMBL5227281

NOCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112051 0.67
Methoxyamine SCHEMBL6298260 0.67
SCHEMBL2560372 0.65
Hydrochloric Acid SCHEMBL28444986 0.65
Hydrochloric Acid SCHEMBL3508421 0.65
Bromide SCHEMBL28390737 0.65
Alcohol SCHEMBL6269479 0.63
SCHEMBL22440201 0.62
SCHEMBL22440195 0.62
Alcohol SCHEMBL10585015 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103254437-B Method for inducing azobenzene liquid crystal elastomer photoinduced deformation by fibroin UNIV SOOCHOW 2015-04-15 CN claimed
WO-2025136125-A1 TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AN ASSOCIATION OF AN ISOXAZOLINE WITH A MACROCYCLIC LACTONE AND A PYRAZINO-ISOQUINOLINE DERIVATIVE FOR TREATING PARASITIC INFESTATIONS IN SMALL ANIMALS AGROVET MARKET S.A. (PE) 2025-06-26 WO disclosed
CN-118001774-A Method for coproducing alkane by preprocessing straws with ionic liquid 河南农业大学 2024-05-10 CN disclosed
CN-116808227-A Polyoxyl (40) stearate combined auxiliary material and preparation method thereof 江苏亚邦强生药业有限公司 2023-09-29 CN disclosed
CN-108752480-B Immunogen composition, preparation method and application thereof 中元汇吉生物技术股份有限公司 2022-03-29 CN disclosed
CN-108752480-A A kind of immunogenic composition, Its Preparation Method And Use 重庆中元汇吉生物技术有限公司 2018-11-06 CN disclosed
CN-103828838-B A kind of herbicidal composition 浙江天丰生物科学有限公司 2016-08-24 CN disclosed
US-9334514-B2 Hybrid polyketide synthases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-05-10 US disclosed
CN-105051133-A Composition for forming cured film, alignment material, and phase difference material NISSAN CHEMICAL IND LTD 2015-11-11 CN disclosed
WO-2015117202-A1 FUNCTIONALISED BENZOPYRAN COMPOUNDS AND USE THEREOF NOVOGEN LIMITED (AU) 2015-08-13 WO disclosed
US-20040058952-A1 Urease inhibitors OTSUKA PHARMACEUTICAL CO., LTD. 2004-03-25 US disclosed
US-20030060482-A1 Urease inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2003-03-27 US disclosed
EP-1262181-A1 UREASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-12-04 EP disclosed
EP-1077698-A4 METABOLITES OF ECTEINASCIDIN 743 PHARMA MAR SA (ES) 2002-05-08 EP disclosed
US-20020032326-A1 Metabolites of ecteinascidin 743 formed by human cytochrome CYP3A4 PHARMA MAR, S.A. (ES) 2002-03-14 US disclosed
US-6316214-B1 AS ANTITUMOR AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2001-11-13 US disclosed
EP-1077698-A1 METABOLITES OF ECTEINASCIDIN 743 PHARMA MAR, S.A. (ES) 2001-02-28 EP disclosed
WO-1999058125-A1 METABOLITES OF ECTEINASCIDIN 743 PHARMA MAR, S.A. (ES) 1999-11-18 WO disclosed
EP-0737193-A1 PYRAZOLOPYRIDINE ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-16 EP disclosed
WO-1995018128-A1 PYRAZOLOPYRIDINE ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-07-06 WO disclosed